NCT06247839View on ClinicalTrials.gov

The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder

PHASE3RecruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

September 10, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

Major Depressive Disorder

Interventions

DRUG

Psilocybin

COMP360 (Brand name of psilocybin to be used)

Trial Locations (1)

02129

RECRUITING

Athinoula A. Martinos Center for Biomedical Imaging, Charlestown

Sponsors

Collaborators (1)

COMPASS Pathways

All Listed Sponsors

collaborator

COMPASS Pathways

INDUSTRY

lead

Sharmin Ghaznavi

OTHER